New

Create, analyze, optimize your ETF portfolio. Start now →

Advertisement

PPHvsPBPHETF Comparison

ETF 1
PPH

VanEck Pharmaceutical ETF

This fund is part of
Uncategorized Equities
+0.65%
VS
ETF 2
PBPH

Portfolio Building Block World Pharma and Biotech Index ETF

This fund is part of
DM Large & Mid Cap
+0.59%

VanEck Pharmaceutical ETF (PPH) belongs to the Uncategorized Equities segment. Portfolio Building Block World Pharma and Biotech Index ETF (PBPH) is part of the DM Large & Mid Cap segment. Both ETFs have the same top 1 sector exposures: Healthcare. PPH is more expensive with a Total Expense Ratio (TER) of 0.36%, versus 0.13% for PBPH. PPH is up 13.99% year-to-date (YTD) with -$310M in YTD flows. PBPH performs better with 17.91% YTD performance, and +$1.00B in YTD flows. Run a side-by-side ETF comparison of PPH and PBPH below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.

Find out how industry players manage ETF portfolios.  Discover our library of Model portfolios

PPH vs PBPH performance and flow charts

Performance

-4.0-2.00.02.04.0%Sep 21Sep 28Oct 5Oct 12Oct 19

Cumulative Flows

-40 M-20 M0 M20 M40 M60 M80 MSep 21Sep 28Oct 5Oct 12Oct 19

Get all the metrics on this page, and more, through a reliable ETF data feed

Daily, global ETF data for advanced analysis or integration into apps (API), from our partner Trackinsight.

Historic performance and flows
Data as of 10/21/2026
1M3MYTD1Y3Y5Y
Perf.
PPH
PBPH
+3.82%+4.28%
+6.00%+11.18%
+13.99%+17.91%
+28.02%n/a
+58.33%n/a
+71.48%n/a
Flows
PPH
PBPH
-$1M+$32M
+$67M+$82M
-$310M+$1.00B
-$387M-
+$362M-
+$455M-
Volatility and drawdown
3M1Y3Y5Y
Volatility
PPH
PBPH
+19.56%+19.45%
+18.33%n/a
+16.40%n/a
+15.75%n/a
Max drawdown
PPH
PBPH
-8.47%-6.98%
-10.78%n/a
-17.98%n/a
-20.19%n/a
Max drawdown duration
PPH
PBPH
57d55d
122dn/a
434dn/a
484dn/a
Trading data

Create an account to view trading data

Join for free
PPH
PBPH
Last sale
10/22/2026 at 1:30 PM
$117.04
$30.15
Previous close
10/21/2026
$115.58
$29.70
Consolidated volume
10/21/2026
Average volume
30 days
Average discount or premium
30 days
Average Bid/Ask spread
30 days
Replication quality
Data as of September 30, 2026
1-year trailing difference

Create an account to view replication metrics

Join for free

Create an account to view replication quality

Join for free
PPH
PBPH
Tracking error
Tracking difference
1 year cumulative return difference
Best
Worst
Daily return difference
Average
Worst
Advertisement
Main metrics
Last update 10/22/2026 at 1:30 PM
Live
Closed
PPH
PBPH
Last price
$117.04
$30.15
1D performance
+1.26%
+1.52%
AuM$1.07 B$1.11 B
E/R0.36%0.13%
Characteristics
PPH
PBPH
Management strategyPassivePassive
ProviderVanEckTidal
BenchmarkMVIS US Listed Pharmaceutical 25 IndexBITA Global Pharma and Biotech Select Index
N° of holdings2552
Asset classEquities-
Trailing 12m distribution yield
Join
Join
Inception dateDecember 20, 2011November 24, 2025
ESGNoNo
Advertisement
Exposure

Countries

PPH
USA
62.46%
United Kingdom
10.95%
Switzerland
10.06%
Other
16.53%
PBPH
USA
66.52%
Switzerland
10.05%
Other
23.44%

Sectors

PPH
Healthcare
100%
Other
0%
PBPH
Healthcare
99.55%
Other
0.45%
Advertisement

Diversification

PPH

Total weight of top 15 holdings out of 15

90.56%
PBPH

Total weight of top 15 holdings out of 15

74.6%

Top 15 holdings

Data as of August 31, 2026
PPH
Eli Lilly & Co.
19.11%
Merck & Co., Inc.
10.96%
Novartis AG
10.06%
Pfizer Inc.
5.05%
Bristol Myers Squibb Co.
4.98%
Novo Nordisk A/S
4.92%
McKesson Corp.
4.70%
AbbVie, Inc.
4.48%
Johnson & Johnson
4.43%
GSK Plc
4.13%
Sanofi
4.06%
Cencora, Inc.
3.68%
AstraZeneca PLC
3.59%
Haleon Plc
3.23%
Teva Pharmaceutical Industries Ltd.
3.17%
PBPH
Eli Lilly & Co.
14.74%
Johnson & Johnson
9.60%
AbbVie, Inc.
6.72%
Merck & Co., Inc.
5.42%
Amgen, Inc.
4.92%
Roche Holding AG
4.59%
Novartis AG
4.14%
Gilead Sciences, Inc.
3.99%
AstraZeneca PLC
3.52%
Pfizer Inc.
3.51%
Novo Nordisk A/S
3.23%
Vertex Pharmaceuticals, Inc.
3.02%
Bristol Myers Squibb Co.
2.99%
Sanofi
2.15%
GSK Plc
2.07%
Frequently asked questions about PPH and PBPH

How have the PPH and PBPH ETFs performed in 2026?

As of October 21, 2026, PPH is up 13.99% year-to-date (YTD), while PBPH has returned 17.91%. That puts PBPH better performer ahead so far this year.

Which ETF is attracting more investor money: PPH or PBPH?

Year-to-date, the PPH ETF saw -$310M in flows, compared to +$1.00B for PBPH.

Which ETF is bigger: PPH or PBPH?

As of October 21, 2026, PPH holds $1.07 B in assets under management (AUM), while PBPH manages $1.11 B.

What sectors do the PPH and PBPH ETFs invest in?

PPH leans toward sectors like Healthcare. Meanwhile, PBPH focuses on Healthcare.

What are the top holdings of the PPH ETF and PBPH ETF?

PPH top holdings include Eli Lilly & Co., Merck & Co., Inc. and Novartis AG. PBPH holds in its top three: Eli Lilly & Co., Johnson & Johnson and AbbVie, Inc..

Which ETF is more diversified: PPH or PBPH?

PPH holds 25 securities with 90.56% of its assets in the top 15. PBPH has 53 securities and a top 15 weight of 74.6%.

Advertisement
Latest news about PPH & PBPH
Advertisement
Advertisement
New Report

ETFs’ Next Act: From Access to Selection

With 1,790 new products launched by July 2026, choosing is harder than ever. Our Global ETF Survey 2026, built on 620 professional investors and allocators, shows how active, fixed income, options-based and thematic ETFs are reshaping fund selection.

Global ETF Survey 2026